🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
This study is a phase Ib/II clinical trial conducted in Chinese adult asthm...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2022-07-05
Trial ID
NCT05382910
A randomized, double-blind, placebo-controlled Phase III clinical trial on ...
Status
Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2025-03-25
Trial ID
NCT06837922
Treatments Being Tested
The purpose of this study is to compare the efficacy of S1 plus paclitaxel ...
Status
Unknown
Location
The First Affiliated Hospital of China Medical University
Start Date
2017-11-01
Trial ID
NCT03990103
Treatments Being Tested
The primary objective of the study is to assess the immunogenicity of Dacli...
Status
Completed
Location
Research Site
Start Date
2011-11
Trial ID
NCT01462318
Treatments Being Tested
Research Topics A randomized, open-label, parallel-group, phase I clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2023-10-23
Trial ID
NCT06277284
This is a randomized, double-blind, placebo-controlled, parallel group stud...
Status
Not Yet Recruiting
Location
The First Hospital Of China Medical University
Start Date
2026-04-17
Trial ID
NCT07540442
Treatments Being Tested
A multicenter, randomized, double-blind, placebo-controlled Phase II/III se...
Status
Recruiting
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2025-03-20
Trial ID
NCT06846385
Treatments Being Tested
The study is to reflect the effectiveness and safety of MG-K10 humanized mo...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2024-01-13
Trial ID
NCT06026891
Treatments Being Tested